Clinical, microbiological, and immunologic responses were evaluated in volunteers vaccinated intradermally with bacille Calmette-Guérin (BCG). Most volunteers (98%) developed ulcerative lesions that drained for a mean { SE of 4.3 { 0.29 weeks. Mycobacterial DNA was detected by a polymerase chain reaction -based amplification technique in biopsy specimens from BCG ulcers 2 weeks after vaccination and in blood specimens 3 days after vaccination. Mycobacteria were cultured from ulcer drainage 2 months after vaccination, demonstrating a prolonged potential risk of contact spread of the vaccine strain. The duration of ulcer drainage was inversely correlated with prevaccination lymphoproliferative (r Å 00.515; P õ .002) and interferon g (r Å 00.841; P õ .002) responses specific to mycobacteria and directly correlated with postvaccination increases in lymphoproliferative (r Å 0.498; P õ .002) and interferon g (r Å 0.688; P õ .02) responses specific to mycobacteria. These results demonstrate the clinical reactogenicity of BCG and the potential risk of contact spread of the vaccine strain and suggest that clinical reactogenicity is a trade-off for the induction of protective mycobacterial immunity.
BCG has been used as a vaccine in humans for ú75 years, vaccination, involving the injection of viable vaccine into a dermal wheal, and percutaneous BCG vaccination, involving and ú3 billion doses have been administered (reviewed in [1] ). BCG is a live-attenuated form of Mycobacterium bovis that can the adsorption of surface-applied vaccine through multiple tiny needle points, are the most common forms of BCG vaccination be associated with local tissue reactions in immunocompetent individuals and serious disseminated vaccine complications in in use worldwide. immunocompromised individuals (detailed analyses of adverse reactions to BCG were presented by Lotte et al. in 1984 [2] ).
See editorial response by Ernst on pages 791 -3. However, this vaccine is considered safe enough for the World Health Organization to recommend that all children in areas
The clinical features associated with cutaneous BCG vacciwhere tuberculosis is highly endemic be vaccinated with BCG nation are not widely known in the United States, and the during infancy [3] . Over the last several decades, attempts have relationships between the reactogenicity and immunogenicity been made to minimize the adverse reactions associated with of these vaccinations have not been well characterized. We BCG vaccination. Cutaneous vaccination has evolved to behave previously demonstrated an association between reactocome the most commonly used method of BCG administration genicity and immunogenicity in comparisons of intradermal and is believed to minimize toxicity and maximize induction of and percutaneous BCG vaccinations [4] . We now describe the delayed-type hypersensitivity to PPD of tuberculin. Cutaneous detailed reactogenicity associated with intradermal BCG vaccivaccinations also minimize the cfu dose of BCG required to nation and present further evidence for correlations between induce positive PPD responses, a practical concern for mass BCG reactogenicity and vaccine-induced immunity. production and community vaccine coverage. Intradermal BCG
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Selection of volunteers, BCG vaccination, and clinical fol-
Informed consent was obtained from all subjects, and the U.S. Department low-up. The study protocols were approved by the Instituof Health and Human Services guidelines for human experimentation were followed in the conduct of this study. All study protocols were approved by tional Review Board, Saint Louis University (St. Louis). Vol- intradermally. The second trial included 36 volunteers who washed with Tris-EDTA buffer, followed by extraction with xylenes and washing with ethanol. These ethanol-washed pelwere randomized to receive Connaught BCG or Tice BCG (Perimmune, Rockville, MD) intradermally. A third trial inlets were suspended in proteinase K digestion buffer and incubated for 3 hours at 55ЊC before phenol-chloroform extraction volved 60 volunteers randomized to receive either intradermal or percutaneous vaccination with Tice BCG and has been parand ethanol precipitation. After suspension in ultrapure water, aliquots of these samples were used as DNA templates in PCR tially described previously [4] . To increase the statistical power of Spearman's rank-order test of correlations between reactoreactions with primers specific to a 285-bp product unique to the Mycobacterium tuberculosis complex [6] . Similar reactions genicity and immunogenicity, BCG-vaccinated individuals from all three vaccine trials were included for analysis. All were set up with primers specific to the human b-globin gene as controls for DNA extraction. other results reported herein were based only on findings for the intradermal BCG -vaccinated individuals enrolled in our
The amplification protocol included 40 cycles of 94ЊC for 15 seconds, 70ЊC for 15 seconds, and 72ЊC for 15 seconds, first two vaccine trials.
Intradermal BCG vaccinations (2 -3 1 10 6 cfu) were given after an initial cycle of 94ЊC for 2 minutes; 25 mM MgCl 2 was used in PCR reactions with DNA extracted from tissue samples, over the left deltoid area in 100 mL of saline. Percutaneous immunization was done by spreading 0.3 mL of the BCG prepaand 20 mM MgCl 2 was used in PCR reactions with DNA extracted from blood samples. The PCR products were dotration (3 -4 1 10 8 CFU/mL) on the surface of intact skin over the left deltoid area followed by superficial perforation of the blotted onto Nytran membranes and hybridized with [g-
32
P] end-labeled oligonucleotide probes specific to an internal seepidermis through the vaccine suspension with a multipronged device supplied by the manufacturer (Perimmune).
quence present in the 285-bp product unique to the M. tuberculosis complex [7] . Hybridization was visualized by exposing Volunteers were clinically assessed on days 3, 7, 14, 28, and 56 after vaccination in the Vaccine Center Clinic, Saint Louis radiolabeled blots to a phosphor screen and then was analyzed on a 425B phosphorimager (Molecular Dynamics, Sunnyvale, University. Measurements of papules, pustules, and ulcerations (in millimeters) were recorded at each visit. Oral temperatures, CA). PCR products also were run on 2% agarose gels, and Southern blotting was performed as previously described [7] local erythema, local tenderness, and regional lymph nodes also were assessed at each visit. In addition, volunteers were to confirm the specificity of the probe hybridization for the 285-bp sequence unique to the M. tuberculosis complex. questioned about the occurrence of systemic symptoms and whether they had missed any work because of adverse reactions Swab specimens of ulcer drainage were inoculated into Septi-Chek AFB mycobacterial culture systems (Becton Dickassociated with their BCG lesions. Measurements of PPD-specific delayed-type hypersensitivity 2 months after BCG vacciinson Microbiology Systems, Cockeysville, MD). Blood samples were collected into ISOSTAT isolator tubes (Wampole nation were done with either aplisol (Parke-Davis, Morris Plains, NJ) or tubersol (Connaught Laboratories) forms of tuLaboratories, Cranbury, NJ), processed by lysis centrifugation, and then inoculated into Septi-Chek AFB mycobacterial culture berculin. Five tuberculin units of Tween-stabilized tuberculin was injected intradermally, resulting in Ç10 mm of wheal systems. All cultures were incubated at 37ЊC with 5% CO 2 for 8 weeks before final reporting of the results. Positive cultures formation. Experienced personnel applied the PPD tests and read the millimeters of induration at 48 -72 hours with the were subcultured onto Löwenstein-Jensen agar slants for biochemical analysis. ballpoint pen technique [5] .
Skin biopsies. Seven volunteers vaccinated intradermally Antigen preparations for in vitro stimulation of peripheral blood mononuclear cells (PBMCs).
Whole-cell lysates of the with BCG were randomly selected for study with serial punch biopsies done on days 7, 14, and 28 after vaccination. TwoErdman strain of M. tuberculosis were obtained from John T. Belisle (Colorado State University, Fort Collins) under the millimeter punch biopsy specimens were obtained from skin immediately adjacent to the vaccination sites. The tissue speciterms of the National Institutes of Health Mycobacterial Reagent contract NO1-AI-25147. These lysates were prepared mens were formalin-fixed and paraffin-embedded, and tissue sections were stained with hematoxylin-eosin stain for microfrom midlogarithmic phase cultures grown on glycerol-alanine salts broth. After washing with PBS, mycobacteria were heatscopic examination. Other tissue sections stained with ZiehlNeelsen stain were examined for acid-fast bacilli. Some tissue killed (80ЊC for 1 hour) and then disrupted by a bead vortex before passage through 0.2-mm filters. sections were processed as described below for use in detection of DNA specific to mycobacteria.
Measurement of lymphoproliferative responses in PBMCs. The kinetics of the proliferation assay and the dose response Detection of mycobacteria by PCR analysis and cultures. DNA from tissue and blood specimens was extracted and amwere optimized in earlier studies [4, 8] . Density gradient purified PBMCs freshly harvested from BCG recipients 2 months plified by PCR analysis with some modifications of a previously reported protocol [6] . DNA samples from formalinafter vaccination were diluted to 1 1 10 5 cells/100 mL in medium (RPMI supplemented with 10% pooled human AB serum, fixed, paraffin-embedded biopsy tissue sections were extracted with xylenes and washed with ethanol. Blood specimens were penicillin, streptomycin, glutamine, and b-mercaptoethanol) and incubated in triplicate wells of 96-well flat-bottomed plates collected in EDTA-containing tubes, and cellular pellets were / 9c64$$ap21 03-15-99 09:38:43 cida UC: CID NOTE. Other than the reactions shown, only a few cases of self-limited regional lymphadenopathy occurred. All ulcerations eventually healed without further complications.
for 6 days in the presence of optimal doses of M. tuberculosis two vaccine trials was 9.0 { 1.0 mm, and 72% of these individuals had a PPD response of §5 mm. PPD responses in the lysate (2 mg/mL) or medium alone at 37ЊC with 5% CO 2 . On intradermal BCG recipients recruited into our intradermal vs. day 6, cultures were pulsed with 0.5 mCi of tritiated thymidine percutaneous BCG vaccine trial were similar and have been and further incubated overnight before measuring cell-associreported previously [4] . ated radioactivity.
Clinical reactogenicity. All 48 volunteers vaccinated intraMeasurement of IFN-g responses. IFN-g responses were dermally with either the Connaught strain or the Tice strain of measured as described previously [4, 8] . Briefly, PBMCs were BCG developed an indurated papule or pustule at the immuniincubated on tissue culture plates (1 -4 1 10 6 cells/mL) with zation site, and all but one of these lesions ulcerated and drained medium alone or M. tuberculosis lysate (2 mg/mL) for 6 days for a mean duration of 4.3 weeks (table 1) . No significant at 37ЊC with 5% CO 2 . Supernatants were collected and stored differences were detected in comparisons of the clinical reactoat 070ЊC. IFN-g was detected in culture supernatants by genicity associated with the two different BCG vaccine strains. ELISA with use of the cytokine-specific antibody pair 400-45/ No temperatures of ú101ЊF or other systemic symptoms were 6 mouse IgG1 antibody to hIFN-g (Chemicon, Temecula, CA) recorded. All immunization sites healed by 2 months after and P-700 rabbit antibody to hIFN-g (Endogen, Boston).
vaccination. None of the volunteers reported any limitations in Statistical analyses. All data analyses were performed their normal working schedules that were related to the local with use of Statistica (StatSoft, Tulsa, OK). Spearman's rankvaccine lesions. As reported previously, only one of 30 percutaorder test was used to study correlations between independent neously vaccinated volunteers developed ulceration at the vacvariables.
cination site [4] .
Histopathology of vaccine lesions. Lymphocytic infiltra-

Results
tions with granuloma formation were observed as early as 7 PPD responses. The mean PPD response { SE for all 48 days after BCG vaccination and persisted for 1 month after vaccination. The typical progression seen in tissue sections 14 intradermal BCG -vaccinated volunteers enrolled into the first Figure 1 . Histopathology of BCG-induced cutaneous ulcerations on a volunteer recipient of BCG vaccine. A, skin biopsy specimen 14 days after vaccination that shows a granulomatous infiltrate composed primarily of epithelioid macrophages and lymphocytes in the subcutaneous fat (hematoxylin-eosin stain; original magnification, 1200). B, skin biopsy specimen 30 days after vaccination that shows a well-formed noncaseating granuloma in the dermis (hematoxylin-eosin stain; original magnification, 1200).
/ 9c64$$ap21
03-15-99 09:38:43 cida UC: CID † No. PCR assays positive/no. PCR assays. DNA extracted from formalin-fixed skin tissue specimens obtained from BCG lesions and DNA extracted from whole blood were amplified by using PCR primers specific to a sequence unique to the Mycobacterium tuberculosis complex. and 30 days after vaccination (from inflammatory infiltrates recipients are compared in figure 3 . The higher the baseline lymphoproliferative reactivity the shorter the duration of ulcercomposed primarily of epithelioid macrophages and lymphocytes to well-formed noncaseating granulomatous reactions) is ation (r Å 00.515; P õ .002). In contrast with these results, the fold increases after vaccination in the lymphoproliferative shown in figure 1 . Acid-fast stains of all tissue sections were uniformly negative. reactivity specific to mycobacteria were directly correlated with the length of ulcer duration (r Å 0.498; P õ .002). It can be Prolonged shedding of viable BCG. We studied ulcer drainage, skin biopsy specimens, and blood samples for eviseen in figure 4 that the fold increases in the lymphoproliferative reactivity specific to mycobacteria were Ç2 logs higher dence of mycobacteria by culture and with a PCR-based detection system (table 2). Cultures of swabs of the drainage from in volunteers with draining ulcerations lasting 4 -6 weeks than the levels detected in volunteers with ulcerations lasting £1 vaccine ulcerations on more than one-half of the volunteers revealed that viable BCG was shed for at least 1 month. Ulcer week. Similar relationships between the duration of ulcer drainage drainage from one volunteer still had viable BCG present 2 months after vaccination. PCR analyses of biopsy specimens and IFN-g responses specific to mycobacteria were observed. The baseline levels of IFN-g responses detected before vacciobtained from skin immediately adjacent to vaccine lesions demonstrated the presence of mycobacterial DNA in most specimens 2 weeks after vaccination. PCR analyses of similar tissue specimens obtained from four volunteers 1 month after vaccination were all negative.
PCR amplification detected circulating mycobacteria in blood samples from three volunteers 3 days after vaccination but never 2, 4, or 8 weeks later. A Southern blot of the amplified products from these blood specimens is shown in figure 2 . The 285-bp amplimer specific to the M. tuberculosis complex was clearly detected, thus demonstrating the specificity of the PCR reactions. Cultures of lysis centrifugation -processed blood were negative for mycobacteria at all times studied, including 3 days after vaccination.
Correlations of reactogenicity with immunogenicity. Previously, we reported results of in vitro studies of cell-mediated immune responses specific to mycobacteria in these BCG-vaccinated volunteers [4, 8] . Now, we present the results of Spear- The other major finding in these studies was that the clinical reactogenicity associated with intradermal BCG vaccination was correlated with immunity specific to mycobacteria. As pointed out above, ulcerative drainage from vaccine lesions contained viable replicating BCG. Direct correlations between the duration of ulcer drainage (relative duration of BCG replication) and lymphoproliferative and IFN-g responses specific to mycobacteria after vaccination were detected (figure 4 and Results). IFN-g is known to be a key cytokine in the induction of effector functions important for the control of intracellular pathogens, including mycobacteria causing human infections whether effective vaccines with less clinical toxicity can be developed to prevent a disease like tuberculosis that largely occurs in the face of immunosuppression. Persons with draining nation in 11 BCG vaccine recipients were inversely correlated BCG ulcers should be advised to cover their ulcerative sites with the duration of ulcer drainage (r Å 00.841; P õ .002), with bandages and dispose of these bandages with proper biobut the fold increases in IFN-g responses 2 months after vaccination were directly correlated with the duration of ulcer drainage (r Å 0.688; P õ .02). Similar results were obtained when these correlations were studied separately in the groups of volunteers receiving the two different BCG vaccine strains (data not shown).
Discussion
Our results are consistent with other reports demonstrating a very high incidence of ulcerative lesions at the immunization sites after intradermal BCG vaccination [2, 9] . We also found that these granulomatous ulcerative lesions drained for about 1 month in most cases and that the ulcer drainage contained viable BCG that could be a source for environmental contact suppressed individuals (reviewed in [10] ). In addition, signifiduration and fold increases in lymphoproliferation specific to mycocant clinical complications have been reported after accidental bacteria in the 37 BCG vaccine recipients for whom results were contact spread of BCG vaccine [11 -16] . Health care workers available for this analysis. Note the logarithmic scale for fold increases in responses specific to mycobacteria.
need to be aware of the probability of viable mycobacteria in / 9c64$$ap21 03-15-99 09:38:43 cida UC: CID
